Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Prostacyclin receptor | ||
Ligand | BDBM464512 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | HTRF assay | ||
EC50 | 73.0±n/a nM | ||
Citation | Tran, T; Hayashi, R; Ibarra, JB; Ullman, B; Zou, N Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulators US Patent US10793529 Publication Date 10/6/2020 | ||
More Info.: | Get all data from this article, Assay Method | ||
Prostacyclin receptor | |||
Name: | Prostacyclin receptor | ||
Synonyms: | PGI receptor | PI2R_HUMAN | PRIPR | PTGIR | Prostacyclin (IP) Receptor | Prostacyclin receptor | Prostaglandin I | Prostaglandin I2 | Prostaglandin I2 receptor | Prostanoid IP receptor | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 40968.22 | ||
Organism: | Homo sapiens (Human) | ||
Description: | The membranes prepared from human platelet were used in binding assay. | ||
Residue: | 386 | ||
Sequence: |
| ||
BDBM464512 | |||
n/a | |||
Name | BDBM464512 | ||
Synonyms: | 2-(((1s,4s)-4-((5-(3- chlorophenyl)-3-oxo-6- phenyl-1,2,4-triazin-2(3H)- yl)methyl)cyclohexyl) methoxy)acetic acid | US10793529, Compound 67 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H26ClN3O4 | ||
Mol. Mass. | 467.945 | ||
SMILES | OC(=O)COC[C@H]1CC[C@@H](Cn2nc(-c3ccccc3)c(nc2=O)-c2cccc(Cl)c2)CC1 |r,wU:9.9,6.5,(9.34,-.77,;8,,;8,1.54,;6.67,-.77,;5.33,,;4,-.77,;2.67,,;1.33,-.77,;;,1.54,;-1.33,2.31,;-2.67,1.54,;-4,2.31,;-5.33,1.54,;-6.67,2.31,;-6.67,3.85,;-8,4.62,;-9.34,3.85,;-9.34,2.31,;-8,1.54,;-5.33,,;-4,-.77,;-2.67,,;-1.33,-.77,;-6.67,-.77,;-8,,;-9.34,-.77,;-9.34,-2.31,;-8,-3.08,;-8,-4.62,;-6.67,-2.31,;1.33,2.31,;2.67,1.54,)| | ||
Structure |